Distribution of baseline characteristics for cases and controls
. | Cases (n = 415) . | Controls (n = 848) . | P . |
---|---|---|---|
C5, μg/mL | 60.4 | 58.2 | .003 |
Age in years, y | 60 ± 14 | 60 ± 14 | .999 |
Male sex | 48.4 (201) | 46.7 (396) | .603 |
BMI, kg/m2 | 27.2 ± 4.5 | 26.1 ± 4.1 | <.001 |
Smoking | 29.5 (123) | 32.0 (271) | .441 |
Diabetes* | 4.1 (17) | 3.9 (33) | .995 |
CVD* | 15.7 (65) | 15.6 (132) | .999 |
Cancer* | 6.2 (26) | 3.7 (31) | .051 |
hsCRP, mg/L | 1.7 ± 1.4 | 1.6 ± 1.4 | .077 |
White blood cell count, ×109/L | 7.2 ± 2.9 | 7.0 ± 1.8 | .177 |
Platelet count, ×109/L | 247 ± 57 | 244 ± 53 | .336 |
. | Cases (n = 415) . | Controls (n = 848) . | P . |
---|---|---|---|
C5, μg/mL | 60.4 | 58.2 | .003 |
Age in years, y | 60 ± 14 | 60 ± 14 | .999 |
Male sex | 48.4 (201) | 46.7 (396) | .603 |
BMI, kg/m2 | 27.2 ± 4.5 | 26.1 ± 4.1 | <.001 |
Smoking | 29.5 (123) | 32.0 (271) | .441 |
Diabetes* | 4.1 (17) | 3.9 (33) | .995 |
CVD* | 15.7 (65) | 15.6 (132) | .999 |
Cancer* | 6.2 (26) | 3.7 (31) | .051 |
hsCRP, mg/L | 1.7 ± 1.4 | 1.6 ± 1.4 | .077 |
White blood cell count, ×109/L | 7.2 ± 2.9 | 7.0 ± 1.8 | .177 |
Platelet count, ×109/L | 247 ± 57 | 244 ± 53 | .336 |
Data are means ± SD or percentages with number of cases or controls in parentheses.
hsCRP, high-sensitivity CRP.
Self-reported history of diabetes, cancer, or CVD (myocardial infarction, angina pectoris, or stroke) at baseline.